Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results

Objectives:To retrospectively evaluate the imaging quality of diffusion-weighted imaging (DWI), compare the apparent diffusion coefficient (ADC) values for malignant and benign tissues in the peripheral zone (PZ) and transition zone (TZ), and evaluate whether T2-weighted imaging (T2WI) with DWI could improve the prediction of prostate cancer location when compared with T2WI at 3T using a phased-array coil. Materials and Methods:Thirty-seven patients underwent T2WI and DWI before radical prostatectomy. The DWI technique with b = 0 and b = 1000 s/mm2 was used. ADC values were measured in benign and malignant tissues in the PZ or TZ. The prediction of prostate cancer location was evaluated in the PZ and TZ using T2WI and T2WI with DWI, respectively. Two readers in consensus recorded the presence of prostate cancer at magnetic resonance imaging and rated the imaging quality of DWI. Results:For the prediction of 68 prostate tumors, the overall sensitivity and positive predictive value of T2WI with DWI were 84% and 86%, whereas those of T2WI were 66% and 63%, respectively (P < 0.05). The mean ADC values of malignant and benign tissues in the PZ and TZ were 1.30 ± 0.26 and 1.96 ± 0.20, and 1.35 ± 0.24 and 1.75 ± 0.23 × 10−3mm2/s, respectively (P < 0.01). The overall imaging quality was satisfactory or better in 97% of patients. Conclusion:DWI is a feasible technique that can be used for the differentiation of malignant and benign tissues in the PZ and TZ. Additionally, T2WI with DWI is superior to T2WI alone for the prediction of prostate cancer location.

[1]  K. Hosseinzadeh,et al.  Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.

[2]  M. Rifkin,et al.  MR imaging characteristics of noncancerous lesions of the prostate , 1992, Journal of magnetic resonance imaging : JMRI.

[3]  Takeo Ishigaki,et al.  Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2005, Journal of magnetic resonance imaging : JMRI.

[4]  S. F. Quinn,et al.  MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. , 1994, Radiology.

[5]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[6]  J. Chapelon,et al.  Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome , 2001, European Urology.

[7]  P H Bland,et al.  Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. , 1991, Radiology.

[8]  C. Kuhl,et al.  Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. , 2005, Radiology.

[9]  Seong Ho Park,et al.  Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization , 2005, Journal of magnetic resonance imaging : JMRI.

[10]  P. Carroll,et al.  Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. , 2004, Radiology.

[11]  M. Zelefsky.  Three-dimensional conformal brachytherapy for prostate cancer , 2004, Current urology reports.

[12]  J R Thornbury,et al.  Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.

[13]  R E Lenkinski,et al.  Current role of MR imaging in the staging of adenocarcinoma of the prostate. , 1993, Radiology.

[14]  Richard Frayne,et al.  Effect of b value on contrast during diffusion‐weighted magnetic resonance imaging assessment of acute ischemic stroke , 2002, Journal of magnetic resonance imaging : JMRI.

[15]  Stefan A Reinsberg,et al.  Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. , 2007, AJR. American journal of roentgenology.

[16]  Fritz Schick,et al.  Whole-body MRI at high field: technical limits and clinical potential , 2005, European Radiology.

[17]  Guglielmo Manenti,et al.  Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer , 2007, Investigative radiology.

[18]  L. Turnbull,et al.  Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.

[19]  T. Gardner,et al.  Prostate cancer therapy with high-intensity focused ultrasound. , 2005, Clinical genitourinary cancer.

[20]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[21]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[22]  T. Scheenen,et al.  Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy. , 2007, Investigative radiology.

[23]  E. Crawford,et al.  Minimally Invasive Surgery in Prostate Cancer: Current and Future Perspectives , 2005, Cancer journal.

[24]  L. Turnbull,et al.  Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[25]  M. Kattan,et al.  Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.

[26]  K C Carriere,et al.  Across time and space: variations in hospital use during Canadian health reform. , 2000, Health services research.

[27]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[28]  H. Hricak,et al.  MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.

[29]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[30]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[31]  L. Dougherty,et al.  High field body MR imaging: preliminary experiences. , 2004, Clinical imaging.

[32]  C. Kim,et al.  Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.